- 2025.2.5
- News Release Revolution in the field of eye diseases: biotech research collaboration between Naples and Tokyo to develop revolutionary therapies
- 2025.2.5
- Patents, Articles & Conferences We are pleased to announce that the results of collaboration project with Prof. Sando Lab (The University of Tokyo) have been accepted and published online in Biomaterials Science.
- 2024.10.2
- Event We will have a booth V-26 at Japan Healthcare Venture Summit 2024 on Oct 9th-11th
- 2024.8.26
- Patents, Articles & Conferences Results of collaboration project with Prof. Sando Lab (The University of Tokyo) will be presented at XXV International Round Table on Nucleosides, Nucleotides and Nucleic Acids (IRT2024)
- 2024.8.8
- Patents, Articles & Conferences We will be presenting Hunner-type Interstitial Cystitis project at ICICJ (August 21st-23rd at Kyoto）
- 2024.7.1
- Patents, Articles & Conferences Announcement of presentation at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan (July 15th – 18th, 2024)
- 2024.5.1
- Patents, Articles & Conferences We will be presenting our Dry eye project results at ARVO 2024 (May 5th – 9th at Seattle）
- 2024.3.13
- News Release Prof. Yohei Yamauchi of ETH Zurich and TAGCyx Announces a Research Collaboration for the discovery of a novel Xenoligo® aptamer in the field of infectious diseases field.
- 2024.3.11
- News Release Shinji Oki, PhD, at National Center of Neurology and Psychiatry and TAGCyx Announces a research collaboration for the treatment for systemic lupus erythematosus using a novel nucleic acid aptamer.
- 2024.2.29
- Patents, Articles & Conferences We will be presenting Xenoligo® Technology at Aptamers 2024 (March 18th – 19th at Oxford）
- 2024.1.31
- News Release SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY
- 2024.1.4
- News Release TAGCyx and Toray Launch Joint Research Initiative to Combat Preeclampsia during Pregnancy as Part of Efforts to Stem Japan’s Declining Birthrate